tolbutamide has been researched along with Bright Disease in 3 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kokot, F | 1 |
Kuska, J | 1 |
Spitz, I | 1 |
Rubenstein, AH | 1 |
Bersohn, I | 1 |
Lawrence, AM | 1 |
Kirsteins, L | 1 |
3 other studies available for tolbutamide and Bright Disease
Article | Year |
---|---|
Clinicopathologic conference No. 121. Maculopapular rash and proteinuria.
Topics: Aged; Diabetes Mellitus; Drug Hypersensitivity; Glomerulonephritis; Humans; Kidney; Male; Polyarteri | 1969 |
[Insulin secretion in chronic kidney failure].
Topics: Adolescent; Adult; Aged; Blood Glucose; Fatty Acids, Nonesterified; Female; Glomerulonephritis; Gluc | 1973 |
The effect of dialysis on the carbohydrate intolerance of chronic renal failure.
Topics: Adult; Blood; Blood Glucose; Carbon Dioxide; Depression, Chemical; Drug Tolerance; Fatty Acids, None | 1970 |